第三组先天性淋巴细胞:对抗类固醇喘的潜在治疗点
Marzhan Berkinbayeva1, Wenjing Gu1,2, Zhifeng Chen1,3
1Division of Allergy and Clinical Immunology, The Johns Hopkins Asthma & Allergy Center, Johns Hopkins University School of Medicine, 5501 Hopkins Bayview Circle, Room 3B.71, Baltimore, MD, 21224, USA.
Clinical reviews in allergy & immunology
|January 3, 2025
概括
类固醇耐药喘 (SRA) 涉及复杂的免疫反应. 3型先天性淋巴细胞 (ILC3s) 正在成为难以治疗的喘的潜在治疗点,提供新的治疗途径.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 细胞生物学 细胞生物学
背景情况:
- 喘在全球影响着数以百万计的人,其中有一部分人对标准的葡萄糖皮质激素治疗有抗性.
- 类固醇耐药喘 (SRA) 涉及复杂的免疫机制,包括Th1/Th17细胞,中性粒细胞和炎症细胞.
- 非酸性喘 (NEA) 和SRA在疾病控制和治疗方面存在重大挑战.
研究的目的:
- 探索SRA的风险因素和机制.
- 巩固有关呼吸道疾病中的先天性淋巴细胞 (ILCs),特别是ILC3s的发现.
- 审查针对NEA和SRA的ILC3途径的新兴治疗生物学药物.
主要方法:
- 文献审查侧重于SRA机制和ILC3参与.
- 对人类疾病和喘中的ILC3s当前研究的分析.
- 对针对ILC3相关途径的治疗生物制剂的数据的综合.
主要成果:
- ILC3s在免疫反应,炎症和组织平衡中起着至关重要的作用,类似于Th17细胞.
- ILC3s有助于NEA的疾病严重程度和皮质类固醇耐药性.
- 针对ILC3通路的新兴生物药物显示出对Th2-低喘,NEA和SRA的承诺.
结论:
- ILC3s代表了理解和治疗SRA的重要研究领域.
- 准与ILC3相关的途径为耐固醇和非酸性喘提供了新的治疗策略.
- 解决ILC3s的作用可以改善挑战性喘病例的管理.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
217
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
217
01:24T Cell Types and Functions
946
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
946
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95